Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
>=10-<20
General Information
Version
2.0
Revision date
2023-08-02
Product name
Trajenta film-coated tablets
Product Synonyms
Trajenta® film-coated tablets 5 mg; Trazenta® film-coated
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., Refer to the product insert for complete instructions on usage
supplier name
Boehringer Ingelheim Pharmaceuticals Inc
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim Pharmaceuticals Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Not a hazardous substance or mixture.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet). This product does not contain titanium dioxide in its respirable form and would not be considered carcinogenic; however, upon crushing, grinding or other processing that could result in the gener- ation of respirable particulates, the Category 2 carcinogenic classification would apply.
2.1 Classification of the substance or mixture
1910.1200) Not a hazardous substance or mixture.
